Education
About Us
Working with TipRanks
Follow Us
Mountain Valley MD (TSE:MVMD)
:MVMD
MVMD Stock Chart & Stats
C$0.02
<C$0.01(20.00%)
At close: 4:00 PM EST
C$0.02
<C$0.01(20.00%)
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.04
Previous CloseN/A
Volume2.00K
Average Volume (3M)205.59K
Market Cap
C$8.81M
Enterprise ValueC$8.58M
Total Cash (Recent Filing)C$316.00K
Total Debt (Recent Filing)C$89.00K
Price to Earnings (P/E)―
Beta-0.09
Next Earnings
Jul 09, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding352,354,950
10 Day Avg. Volume152,980
30 Day Avg. Volume205,595
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)3.44
Price to Sales (P/S)177.77
P/FCF Ratio-2.23
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Very Low Leverage (near-zero Debt)Near-zero reported debt is a durable financial strength: it reduces fixed interest obligations, lowers default risk, and preserves flexibility to raise growth capital on better terms. Over 2–6 months this improves survivability during cash burn and supports strategic options.
Return To Positive Gross Profit (2025)A positive gross profit in 2025 indicates product-level economics can be positive once direct costs are covered. This provides a structural foundation for future operating leverage: if SG&A is controlled, incremental revenue can flow to operating profit over time.
Controlled Cash Burn TrendStable (non-spiking) negative operating cash flow shows management has contained incremental deterioration. Predictable burn, even if negative, aids planning for financing rounds and reduces short-term liquidity shocks, an advantage during capital raises.
Bears Say
Deep, Persistent Net LossesSustained multi-million-dollar net losses indicate core operations are not yet profitable and require ongoing funding. Over 2–6 months this undermines free-cash-flow generation, increases reliance on external capital, and can force dilutive financing or cost-cutting that impairs growth.
Sharply Reduced Equity CushionA collapsing equity base materially weakens the balance sheet buffer against losses and constrains financing flexibility. With limited shareholder equity, the company faces higher dilution risk and reduced creditor confidence, making capital raises more costly or difficult.
Minimal, Volatile RevenueVery small and highly volatile revenue signals weak product-market traction and uncertain scalability. Over a multi-month horizon this reduces visibility into future cash flows, impedes fixed-cost coverage, and makes sustainable margin expansion unlikely without new commercial wins.
Mountain Valley MD News
MVMD FAQ
What was Mountain Valley MD’s price range in the past 12 months?
Mountain Valley MD lowest stock price was C$0.01 and its highest was C$0.04 in the past 12 months.
What is Mountain Valley MD’s market cap?
Mountain Valley MD’s market cap is C$8.81M.
When is Mountain Valley MD’s upcoming earnings report date?
Mountain Valley MD’s upcoming earnings report date is Jul 09, 2026 which is in 115 days.
How were Mountain Valley MD’s earnings last quarter?
Mountain Valley MD released its earnings results on Mar 02, 2026. The company reported -C$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.002.
Is Mountain Valley MD overvalued?
According to Wall Street analysts Mountain Valley MD’s price is currently Overvalued.
Does Mountain Valley MD pay dividends?
Mountain Valley MD does not currently pay dividends.
What is Mountain Valley MD’s EPS estimate?
Mountain Valley MD’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mountain Valley MD have?
Mountain Valley MD has 352,354,950 shares outstanding.
What happened to Mountain Valley MD’s price movement after its last earnings report?
Mountain Valley MD reported an EPS of -C$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 33.333%.
Which hedge fund is a major shareholder of Mountain Valley MD?
Currently, no hedge funds are holding shares in TSE:MVMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mountain Valley MD
Mountain Valley MD Holdings Inc., through its subsidiary, Mountain Valley MD Inc., operates as a health and wellness company. The company engages in the implementation and licensing of its technologies to pharmaceutical, vaccine, and nutraceutical third parties. It offers Quicksome oral drug formulation and delivery technologies; Quicksol solubility formulation technology; and dose sparing adjuvant. In addition, the company is developing IM032 for the treatment of male beagle dogs for comparing intramuscular and subcutaneous dosing. Mountain Valley MD Holdings Inc. is headquartered in Concord, Canada.
Technical Analysis
Ayurcann Holdings Corp.
―
Revive Therapeutics
―
PharmaCielo
―
CanadaBis Capital
―
Lobe Sciences
―
Options Prices
Currently, No data available
---